The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.
about
A novel laser-Doppler flowmetry assisted murine model of acute hindlimb ischemia-reperfusion for free flap researchMitochondrial Regulation of the Muscle Microenvironment in Critical Limb IschemiaLower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemiaOptical probing of gastrocnemius in patients with peripheral artery disease characterizes myopathic biochemical alterations and correlates with stage of disease.LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?A functional murine model of hindlimb demand ischemia.Greater endothelial apoptosis and oxidative stress in patients with peripheral artery diseaseImpaired skeletal muscle repair after ischemia-reperfusion injury in miceCrossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.Abnormal joint powers before and after the onset of claudication symptoms.Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective.Gender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.Surface-enhanced Raman spectral biomarkers correlate with Ankle Brachial Index and characterize leg muscle biochemical composition of patients with peripheral arterial disease.Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle.Gait variability of patients with intermittent claudication is similar before and after the onset of claudication painAbnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment.A review of the pathophysiology and potential biomarkers for peripheral artery disease.Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia.Abnormal myofiber morphology and limb dysfunction in claudication.External work is deficient in both limbs of patients with unilateral PADPeripheral arterial disease affects the frequency response of ground reaction forces during walkingTransforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease.Vascular occlusion affects gait variability patterns of healthy younger and older individuals.Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage.From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration.Exercise training and peripheral arterial disease.Gastrocnemius mitochondrial respiration: are there any differences between men and women?Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational studyHuman enterovirus in the gastrocnemius of patients with peripheral arterial disease.Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication.Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease.Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T-cell polarization during early and late stagesMitochondrial Bioenergetics in the Metabolic Myopathy Accompanying Peripheral Artery Disease.A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.Intermittent claudication: new targets for drug development.Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.Blood pressure and calf muscle oxygen extraction during plantar flexion exercise in peripheral artery disease.Development of an in vitro model of myotube ischemia.
P2860
Q21133012-497368E7-B763-496D-91B8-15C4EAD9E496Q26774784-9A4390F1-B153-4C0F-8C5B-0CD5C953C9DAQ28084776-DC0AA809-0859-40E4-AEA9-61EE22B5586FQ30360841-6A918B3E-1E94-401B-907D-358B1FDD6A11Q30422549-C5B8BA39-B68D-4175-9D2A-41D25F6A1FB5Q33549031-6BC994A3-BE6F-49C6-A234-0AA24F5EA707Q33745594-718FCE25-128C-4B7A-A6E4-513F0271E892Q33836541-26B3E1E9-EBA2-4043-996B-53578E7A4157Q33885504-69BF2620-6237-44F6-92D8-05E89CC054A3Q34066383-863A08C8-520F-4B84-B6D2-13735C15F9BFQ34085963-14044374-7531-422D-8717-DD36FDA47C67Q34288235-6258057D-F35A-4E19-A352-BD9F6EEE4A5DQ34730585-066896E6-044C-4FCF-981D-912F5C27B693Q34755828-9650B4F2-E1CA-463B-8D71-DF3191ED3070Q35100221-04130D69-9B9C-46D9-AC59-4E12706FB84AQ35217900-1A2B6596-5562-416B-A1D8-8F6160A0AEABQ35621136-0A7863AE-3A05-4FC3-9BD4-7BD3B5E62E34Q35723731-9E63871D-3109-4B0D-9DE9-01C6B417C897Q35791682-0391AC3E-EB0A-4770-9225-1D5856CEFBA3Q35882665-19825BF5-096B-4B1B-8168-E2B19C84244EQ35990250-1ED5303A-588E-4BD0-8314-24C55F3E5F17Q36409488-E310F61B-57EF-486B-9C4D-4F1F92B2F81DQ36549555-C41BF3D9-8546-4009-8F53-A68F1F8EDA10Q36598625-BA860060-BC6F-4DA5-979D-9DE1449FC754Q36808114-21E3CED5-824B-42FA-8842-FE874F0A040EQ36923569-A291C329-B708-4684-BCE8-D2688B2E194CQ37094150-39658979-02AA-4334-AF5E-5D1A8D595092Q37157213-F2890955-9C88-4070-ABFD-7C136AA49D16Q37248528-72C55F79-9BC9-416A-BB55-15323D1251E7Q37299323-292CAD1A-2444-4BA0-958F-36E1F5CD215FQ37310417-79901B92-EDAB-4806-B171-2E13C91EFB65Q37344502-CA212F5C-8FE5-4908-BB57-ABC755989E55Q37361610-CA111067-FED9-4218-AD25-3111963F8711Q37664155-E809A77C-A8CA-4A55-9B1A-B73CB7E379E5Q37694486-819F04CC-CD90-4EFC-A479-4AB523BE49B9Q38074225-5371E1BC-2413-407B-91F2-1D7208B87D80Q38115205-D074D93A-E800-44FF-8F44-5451E7B79614Q38807921-8C3ABA9C-61E3-4539-910C-9010381E4E6EQ38849063-2812E5BF-73C1-44D1-B0FD-FC374E3691EDQ39537577-B563BF35-57B9-4126-8E3A-86F9EC8E895A
P2860
The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The myopathy of peripheral art ...... nd shift in muscle fiber type.
@en
The myopathy of peripheral art ...... nd shift in muscle fiber type.
@nl
type
label
The myopathy of peripheral art ...... nd shift in muscle fiber type.
@en
The myopathy of peripheral art ...... nd shift in muscle fiber type.
@nl
prefLabel
The myopathy of peripheral art ...... nd shift in muscle fiber type.
@en
The myopathy of peripheral art ...... nd shift in muscle fiber type.
@nl
P2093
P356
P1476
The myopathy of peripheral art ...... and shift in muscle fiber type
@en
P2093
Aikaterini A Nella
Andrew R Judge
Iraklis I Pipinos
Stanley A Swanson
Stephen L Dodd
P304
P356
10.1177/1538574408315995
P577
2008-04-07T00:00:00Z